Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Perilipin 2 downregulation in β cells impairs insulin secretion under nutritional stress and damages mitochondria
Akansha Mishra, Siming Liu, Joseph Promes, Mikako Harata, William Sivitz, Brian Fink, Gourav Bhardwaj, Brian T. O’Neill, Chen Kang, Rajan Sah, Stefan Strack, Samuel Stephens, Timothy King, Laura Jackson, Andrew S. Greenberg, Frederick Anokye-Danso, Rexford S. Ahima, James Ankrum, Yumi Imai
Akansha Mishra, Siming Liu, Joseph Promes, Mikako Harata, William Sivitz, Brian Fink, Gourav Bhardwaj, Brian T. O’Neill, Chen Kang, Rajan Sah, Stefan Strack, Samuel Stephens, Timothy King, Laura Jackson, Andrew S. Greenberg, Frederick Anokye-Danso, Rexford S. Ahima, James Ankrum, Yumi Imai
View: Text | PDF
Research Article Endocrinology Metabolism

Perilipin 2 downregulation in β cells impairs insulin secretion under nutritional stress and damages mitochondria

  • Text
  • PDF
Abstract

Perilipin 2 (PLIN2) is a lipid droplet (LD) protein in β cells that increases under nutritional stress. Downregulation of PLIN2 is often sufficient to reduce LD accumulation. To determine whether PLIN2 positively or negatively affects β cell function under nutritional stress, PLIN2 was downregulated in mouse β cells, INS1 cells, and human islet cells. β Cell–specific deletion of PLIN2 in mice on a high-fat diet reduced glucose-stimulated insulin secretion (GSIS) in vivo and in vitro. Downregulation of PLIN2 in INS1 cells blunted GSIS after 24-hour incubation with 0.2 mM palmitic acid. Downregulation of PLIN2 in human pseudoislets cultured at 5.6 mM glucose impaired both phases of GSIS, indicating that PLIN2 is critical for GSIS. Downregulation of PLIN2 decreased specific OXPHOS proteins in all 3 models and reduced oxygen consumption rates in INS1 cells and mouse islets. Moreover, we found that PLIN2-deficient INS1 cells increased the distribution of a fluorescent oleic acid analog to mitochondria and showed signs of mitochondrial stress, as indicated by susceptibility to fragmentation and alterations of acyl-carnitines and glucose metabolites. Collectively, PLIN2 in β cells has an important role in preserving insulin secretion, β cell metabolism, and mitochondrial function under nutritional stress.

Authors

Akansha Mishra, Siming Liu, Joseph Promes, Mikako Harata, William Sivitz, Brian Fink, Gourav Bhardwaj, Brian T. O’Neill, Chen Kang, Rajan Sah, Stefan Strack, Samuel Stephens, Timothy King, Laura Jackson, Andrew S. Greenberg, Frederick Anokye-Danso, Rexford S. Ahima, James Ankrum, Yumi Imai

×

Figure 4

Downregulation of PLIN2 dysregulates insulin secretion and [Ca]i in INS1 cells.

Options: View larger image (or click on image) Download as PowerPoint
Downregulation of PLIN2 dysregulates insulin secretion and [Ca]i in INS1...
(A) TG contents corrected for protein contents in Scr and SiPLIN2 transfected INS1 cells. n = 6. (B–E) Insulin secretion at indicated concentrations of glucose in INS1 cells transfected by Scr and SiPLIN2 and preincubated with or without 0.2 mM palmitic acids (PA) for 24 hours. Three experiments each in triplicates. (B) Insulin secretion corrected for mg protein was expressed taking the average of Scr-treated at 2.5 mM for each experiment as 1. n = 9. (C) Stimulation index determined as the ratio of average insulin secretion at 12 mM glucose over 2.5 mM glucose for each experiment. n = 3. (D) Total insulin contents for B were corrected for mg protein and expressed taking the average of Scr-treated at 2.5 mM as 1. n = 9. (E) Insulin secretion at 2.5 mM glucose per total insulin content (%) was expressed taking the average of Scr-treated at 2.5 mM for each experiment as 1. n = 9. (F and G) Fura-2 [Ca]i transients in INS1 cells in response to 30 mM glucose was measured in 4 cover slips for Scr and 5 for SiPLIN2. (F) Glucose response calculated as Fura-2 340/380 as in Methods. (G) Representative average tracings. n = 8 cells for Scr and 14 cells for SiPLIN2 per cover slide. Supplemental Figure 4D shows tracing of an individual cell. All data are mean ± SEM, except for B. *P < 0.05 by Student’s t test for (A and F). One-way ANOVA with Sidak’s post hoc test (B, D, and E) or Bonferroni’s post hoc test (C) were performed for multiple comparisons. *P < 0.05 as indicated for B, C, and E; &P < 0.05 versus Scr at the same concentrations of glucose and PA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts